Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 May 15;134(10):1129–1132.

Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.

J L Cox, A I Gotlieb
PMCID: PMC1491035  PMID: 2938706

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has been used clinically for 8 years and is becoming widely accepted in the treatment of atherosclerotic coronary artery disease. Since the long-term effects of the procedure are unknown, the rate of restenosis following the procedure, approximately 30%, is of major concern. We briefly review the current status of PTCA and the effect of angioplasty on the vessel wall and discuss proposed mechanisms of recurrent stenosis.

Full text

PDF
1129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin G. E., Ratliff N. B., Hollman J., Tabei S., Phillips D. F. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985 Aug;6(2):369–375. doi: 10.1016/s0735-1097(85)80174-1. [DOI] [PubMed] [Google Scholar]
  2. Block P. C., Baughman K. L., Pasternak R. C., Fallon J. T. Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation. 1980 Apr;61(4):778–785. doi: 10.1161/01.cir.61.4.778. [DOI] [PubMed] [Google Scholar]
  3. Bruschke A. V., Wijers T. S., Kolsters W., Landmann J. The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients. Circulation. 1981 Mar;63(3):527–536. doi: 10.1161/01.cir.63.3.527. [DOI] [PubMed] [Google Scholar]
  4. Castaneda-Zuniga W. R., Formanek A., Tadavarthy M., Vlodaver Z., Edwards J. E., Zollikofer C., Amplatz K. The mechanism of balloon angioplasty. Radiology. 1980 Jun;135(3):565–571. doi: 10.1148/radiology.135.3.7384437. [DOI] [PubMed] [Google Scholar]
  5. Cowley M. J., Dorros G., Kelsey S. F., Van Raden M., Detre K. M. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984 Jun 15;53(12):12C–16C. doi: 10.1016/0002-9149(84)90738-0. [DOI] [PubMed] [Google Scholar]
  6. Cunningham D. A., Kumar B., Siegel B. A., Gilula L. A., Totty W. G., Welch M. J. Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy. Radiology. 1984 May;151(2):487–490. doi: 10.1148/radiology.151.2.6231656. [DOI] [PubMed] [Google Scholar]
  7. Faxon D. P., Kelsey S. F., Ryan T. J., McCabe C. H., Detre K. Determinants of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung, and Blood Institute Registry. Am Heart J. 1984 Oct;108(4 Pt 1):1019–1023. doi: 10.1016/0002-8703(84)90470-8. [DOI] [PubMed] [Google Scholar]
  8. Faxon D. P., Sanborn T. A., Haudenschild C. C., Ryan T. J. Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol. 1984 Jun 15;53(12):72C–76C. doi: 10.1016/0002-9149(84)90751-3. [DOI] [PubMed] [Google Scholar]
  9. Faxon D. P., Weber V. J., Haudenschild C., Gottsman S. B., McGovern W. A., Ryan T. J. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis. 1982 Mar-Apr;2(2):125–133. doi: 10.1161/01.atv.2.2.125. [DOI] [PubMed] [Google Scholar]
  10. Gotlieb A. I. Smooth muscle and endothelial cell function in the pathogenesis of atherosclerosis. Can Med Assoc J. 1982 Apr 15;126(8):903–908. [PMC free article] [PubMed] [Google Scholar]
  11. Groves H. M., Kinlough-Rathbone R. L., Richardson M., Jørgensen L., Moore S., Mustard J. F. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest. 1982 Jun;46(6):605–612. [PubMed] [Google Scholar]
  12. Holmes D. R., Jr, Vlietstra R. E., Smith H. C., Vetrovec G. W., Kent K. M., Cowley M. J., Faxon D. P., Gruentzig A. R., Kelsey S. F., Detre K. M. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984 Jun 15;53(12):77C–81C. doi: 10.1016/0002-9149(84)90752-5. [DOI] [PubMed] [Google Scholar]
  13. Ischinger T., Gruentzig A. R., Hollman J., King S., 3rd, Douglas J., Meier B., Bradford J., Tankersley R. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation. 1983 Jul;68(1):148–154. doi: 10.1161/01.cir.68.1.148. [DOI] [PubMed] [Google Scholar]
  14. Kent K. M., Bentivoglio L. G., Block P. C., Bourassa M. G., Cowley M. J., Dorros G., Detre K. M., Gosselin A. J., Gruentzig A. R., Kelsey S. F. Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. Am J Cardiol. 1984 Jun 15;53(12):27C–31C. doi: 10.1016/0002-9149(84)90741-0. [DOI] [PubMed] [Google Scholar]
  15. Kinney T. B., Chin A. K., Rurik G. W., Finn J. C., Shoor P. M., Hayden W. G., Fogarty T. J. Transluminal angioplasty: a mechanical-pathophysiological correlation of its physical mechanisms. Radiology. 1984 Oct;153(1):85–89. doi: 10.1148/radiology.153.1.6236478. [DOI] [PubMed] [Google Scholar]
  16. Levine S., Ewels C. J., Rosing D. R., Kent K. M. Coronary angioplasty: clinical and angiographic follow-up. Am J Cardiol. 1985 Mar 1;55(6):673–676. doi: 10.1016/0002-9149(85)90134-1. [DOI] [PubMed] [Google Scholar]
  17. Libow M., Gruentzig A. R., Greene L. Percutaneous transluminal coronary angioplasty. Curr Probl Cardiol. 1985 Jun;10(6):1–55. doi: 10.1016/0146-2806(85)90015-5. [DOI] [PubMed] [Google Scholar]
  18. Mabin T. A., Holmes D. R., Jr, Smith H. C., Vlietstra R. E., Reeder G. S., Bresnahan J. F., Bove A. A., Hammes L. N., Elveback L. R., Orszulak T. A. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation. 1985 Apr;71(4):754–760. doi: 10.1161/01.cir.71.4.754. [DOI] [PubMed] [Google Scholar]
  19. Meier B. Benign coronary perforation during percutaneous transluminal coronary angioplasty. Br Heart J. 1985 Jul;54(1):33–35. doi: 10.1136/hrt.54.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meier B., Gruentzig A. R., King S. B., 3rd, Douglas J. S., Hollman J., Ischinger T., Galan K. Higher balloon dilatation pressure in coronary angioplasty. Am Heart J. 1984 Apr;107(4):619–622. doi: 10.1016/0002-8703(84)90305-3. [DOI] [PubMed] [Google Scholar]
  21. Meyer J., Schmitz H. J., Kiesslich T., Erbel R., Krebs W., Schulz W., Bardos P., Minale C., Messmer B. J., Effert S. Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results. Am Heart J. 1983 Nov;106(5 Pt 1):973–980. doi: 10.1016/0002-8703(83)90640-3. [DOI] [PubMed] [Google Scholar]
  22. Mizuno K., Kurita A., Imazeki N. Pathological findings after percutaneous transluminal coronary angioplasty. Br Heart J. 1984 Nov;52(5):588–590. doi: 10.1136/hrt.52.5.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pope C. F., Ezekowitz M. D., Smith E. O., Rapoport S., Glickman M., Sostman H. D., Zaret B. L. Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy. Am J Cardiol. 1985 Feb 1;55(4):495–497. doi: 10.1016/0002-9149(85)90400-x. [DOI] [PubMed] [Google Scholar]
  24. Rentrop K. P. Thrombolytic therapy in patients with acute myocardial infarction. Circulation. 1985 Apr;71(4):627–631. doi: 10.1161/01.cir.71.4.627. [DOI] [PubMed] [Google Scholar]
  25. Sabbah H. N., Khaja F., Brymer J. F., Hawkins E. T., Stein P. D. Blood velocity in the right coronary artery: relation to the distribution of atherosclerotic lesions. Am J Cardiol. 1984 Apr 1;53(8):1008–1012. doi: 10.1016/0002-9149(84)90627-1. [DOI] [PubMed] [Google Scholar]
  26. Sanborn T. A., Faxon D. P., Haudenschild C., Gottsman S. B., Ryan T. J. The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis. Circulation. 1983 Nov;68(5):1136–1140. doi: 10.1161/01.cir.68.5.1136. [DOI] [PubMed] [Google Scholar]
  27. Sriram R., Mullen G. M., Foschi A., Bicoff J. P. Percutaneous transluminal coronary angioplasty in acute myocardial infarction without prior thrombolytic therapy. Am J Cardiol. 1985 Mar 1;55(6):842–843. doi: 10.1016/0002-9149(85)90168-7. [DOI] [PubMed] [Google Scholar]
  28. Thornton M. A., Gruentzig A. R., Hollman J., King S. B., 3rd, Douglas J. S. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation. 1984 Apr;69(4):721–727. doi: 10.1161/01.cir.69.4.721. [DOI] [PubMed] [Google Scholar]
  29. Waller B. F., McManus B. M., Gorfinkel H. J., Kishel J. C., Schmidt E. C., Kent K. M., Roberts W. C. Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients. Am J Cardiol. 1983 Jan 1;51(1):81–84. doi: 10.1016/s0002-9149(83)80015-0. [DOI] [PubMed] [Google Scholar]
  30. Willman V. L. Percutaneous transluminal coronary angioplasty, a 1985 perspective. Circulation. 1985 Feb;71(2):189–192. doi: 10.1161/01.cir.71.2.189. [DOI] [PubMed] [Google Scholar]
  31. Zarins C. K., Lu C. T., Gewertz B. L., Lyon R. T., Rush D. S., Glagov S. Arterial disruption and remodeling following balloon dilatation. Surgery. 1982 Dec;92(6):1086–1095. [PubMed] [Google Scholar]
  32. de Feyter P. J., Serruys P. W., van den Brand M., Balakumaran K., Mochtar B., Soward A. L., Arnold A. E., Hugenholtz P. G. Emergency coronary angioplasty in refractory unstable angina. N Engl J Med. 1985 Aug 8;313(6):342–346. doi: 10.1056/NEJM198508083130602. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES